TP53 and cancer: Importantly, DDR activation precedes GIN, represented by the occurrence of p53 mutations and/or defects in DNA damage signaling [36,70], indicating that early in tumorigenesis (before GIN), human cells activate an ATR/ATM-regulated DNA damage response network that delays or prevents cancer.